Patents Assigned to IMMUNESURE LLC
  • RNA-based adjuvant to enhance the immune response to vaccines and therapeutics
    Patent number: 12582711
    Abstract: Described herein are antisense inhibitor adjuvant compositions comprising modified nucleotide sequences complementary to a Homo sapiens interleukin 10 (IL-10) or interleukin 10 receptor alpha (IL-10RA) genes and methods for use thereof.
    Type: Grant
    Filed: August 18, 2022
    Date of Patent: March 24, 2026
    Assignee: IMMUNESURE LLC
    Inventors: Patrick Iversen, Nickolas Kipshidze, Nodar Kipshidze